The number of high-quality genomes is rapidly increasing across taxa. However, it remains limited for coral reef fish of the Pomacentrid family, with most research focused on anemonefish. Here, we present the first assembly for a Pomacentrid of the genus . Using PacBio long-read sequencing with 94.5× coverage, the genome of the Sapphire Devil, , was assembled and annotated. The final assembly comprises 896 Mb pairs across 91 contigs, with a BUSCO completeness of 97.6%, and 28,173 genes. Comparative analyses with chromosome-scale assemblies of related species identified contig-chromosome correspondences. This genome will be useful as a comparison to study specific adaptations linked to the symbiotic life of closely related anemonefish. Furthermore, is found in most tropical coastal areas of the Indo-West Pacific and could become a model for environmental monitoring. This work will expand coral reef research efforts, highlighting the power of long-read assemblies to retrieve high quality genomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711634 | PMC |
| http://dx.doi.org/10.46471/gigabyte.144 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The genome of the sapphire damselfish : a new resource to support further investigation of the evolution of Pomacentrids.
GigaByte
December 2024
Marine Eco-Evo-Devo Unit, Okinawa Institute of Science and Technology, 904-0495, Onna-son, Okinawa, Japan.
The number of high-quality genomes is rapidly increasing across taxa. However, it remains limited for coral reef fish of the Pomacentrid family, with most research focused on anemonefish. Here, we present the first assembly for a Pomacentrid of the genus .
View Article and Find Full Text PDFCardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis.
BMJ Open Gastroenterol
January 2025
Inflammatory Bowel Disease Center and Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Objective: Etrasimod is an oral, once-daily, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment of moderately to severely active ulcerative colitis (UC). S1P receptor expression on cardiac cells is involved in cardiac conduction. We report cardiovascular treatment-emergent adverse events (TEAEs) associated with S1P receptor modulators and other cardiovascular events in the etrasimod UC clinical programme.
View Article and Find Full Text PDFBiomineralization of Human Genomic DNA into ZIF-8, a Zeolite-Like Metal-Organic Framework.
Sovrem Tekhnologii Med
October 2024
Head of the Laboratory of New Medical Materials and Technologies, Professional Center for Education and Research in Genetic and Laboratory Technologies; Samara State Medical University, 89 Chapaevskaya St., Samara, 443099, Russia.
Unlabelled: was to assess the capabilities of human genomic DNA biomineralization into ZIF-8 metal-organic framework (MOF) preserving DNA sequence integrity after the encapsulation cycle and composite dissolving. The study is an initial stage of the project aimed at developing an abiotic vector to be used when working with native nucleic acids of an arbitrary size based on DNA@ZIF-8 composite.
Materials And Methods: We studied human genomic DNA isolated from lymphocytes of peripheral blood of healthy volunteers using Proba-NK kit (DNA-Technology LLC, Russia).
SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins.
Microorganisms
September 2024
Microbiology Lab, Corewell Health, Grand Rapids, MI 49503, USA.
As of 2024, SARS-CoV-2 continues to propagate and drift as an endemic virus, impacting healthcare for years. The largest sequencing initiative for any species was initiated to combat the virus, tracking changes over time at a full virus base-pair resolution. The SARS-CoV-2 sequencing represents a unique opportunity to understand selective pressures and viral evolution but requires cross-disciplinary approaches from epidemiology to functional protein biology.
View Article and Find Full Text PDFReal-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review.
J Manag Care Spec Pharm
September 2024
Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Article Synopsis
- A systematic review was conducted to evaluate the effectiveness and safety of advanced therapies for moderate-to-severe ulcerative colitis (UC) using real-world evidence from studies published between 2005 and 2022.
- Out of nearly 4,000 articles screened, 139 studies were included, focusing mainly on single-agent therapies like vedolizumab, tofacitinib, and adalimumab, with varying rates of clinical remission and adverse events.
- Findings suggested that tofacitinib generally had higher remission rates compared to vedolizumab and anti-TNFα agents, while safety profiles were consistent across different therapies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!